N
Neuland Laboratories
NEULANDLAB Share Price
Healthcare14,982.00
as on 15 Apr 2026 at 15:43
Market Cap
₹19,222 Cr
PE Ratio
104.10
ROCE
20.69%
NEULANDLAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
19,222
PE Ratio
104.10
PB Ratio
11.52
Dividend Yield
0.08%
ROE
17.06%
ROCE
20.69%
Book Value (₹)
1,262.09
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 32.68% | 32.68% | 32.64% | 32.63% | 32.63% |
| Domestic Institutional Investors (DII) | 10.97% | 11.57% | 13.54% | 14.71% | 15.84% |
| Foreign Institutional Investors (FII) | 22.11% | 21.69% | 20.60% | 20.90% | 20.46% |
| Public Investors | 25.86% | 25.55% | 24.72% | 24.31% | 23.84% |
| Government | 0.40% | 0.40% | 0.40% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NEULANDLAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
524558
NSE Scrip Name
NEULANDLAB
ISIN
INE794A01010



